SM
ABBV icon

Sweeney & Michel’s AbbVie ABBV Stock Holding History

Sweeney & Michel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Sell
9,930
-109
-1% -$23.5K 0.64% 26
2026
Q1 		$2.07M Sell
10,039
-121
-1% -$26.8K 0.61% 32
2025
Q4 		$2.24M Buy
10,160
+81
+0.8% +$18.5K 0.66% 29
2025
Q3 		$2.32M Buy
10,079
+43
+0.4% +$8.76K 0.78% 27
2025
Q2 		$1.93M Buy
10,036
+162
+2% +$30.1K 0.69% 29
2025
Q1 		$1.73M Buy
+9,874
New +$1.92M 0.76% 27
2024
Q3 		$1.78M Buy
9,426
+305
+3% +$56.9K 0.7% 28
2024
Q2 		$1.53M Buy
9,121
+57
+0.6% +$9.44K 0.65% 28
2024
Q1 		$1.46M Buy
+9,064
New +$1.56M 0.65% 27
2023
Q3 		$1.33M Buy
9,378
+60
+0.6% +$8.81K 0.7% 27
2023
Q2 		$1.39M Sell
9,318
-533
-5% -$78.2K 0.72% 22
2023
Q1 		$1.33M Buy
+9,851
New +$1.51M 0.71% 24

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sweeney & Michel's ABBV Position: Q2 2026 in Review

Sweeney & Michel reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $23.5K and leaving 9,930 shares worth $2.44M. The position accounts for 0.64% of the portfolio, ranked #26.

Sweeney & Michel first reported a position in ABBV in Q1 2023 and has held it in 12 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sweeney & Michel held 9,930 shares of AbbVie worth $2.44M as of Q2 2026.
  • Sweeney & Michel sold 109 AbbVie shares in Q2 2026, an estimated $23.5K.
  • AbbVie made up 0.64% of Sweeney & Michel's portfolio in Q2 2026, its #26 holding.
  • Sweeney & Michel first reported a position in AbbVie in Q1 2023 and has held it in 12 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sweeney & Michel's 13F filing for Q2 2026, filed 11 Aug 2026.